EUVIMEDEUVIMED entdecken
Crossref

A Novel Metal‐Phenolic‐Protein Hybrid Nanoparticles With Precise Delivery and Enhanced Penetration Effect for tPA Targeted Thrombolysis and Reduced Hemorrhagic Risk

Xinyi Zhao iD, Wendie Wang, Jing Shi, Qi Zhou, Zitong Zhao, Chenyang Li, Mingshuai Tang, Jing Wang, Jing Zhao, Hong Zhang, Jing Qin iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202503684 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xinyi Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmaceutical Sciences, Fudan University & Key Laboratory of Smart Drug Delivery, Ministry of Education & Nat…. Hauptthemen laut MEDLINE: Tissue Plasminogen Activator, Thrombolytic Therapy, Nanoparticles, Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Open Project Program of Key Lab of Smart Drug Delivery (Fudan University).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ischemic stroke (IS) is a leading cause of mortality and disability worldwide, posing a critical public health challenge. Currently, clinical use of tissue plasminogen activator (tPA) for IS thrombolytic treatment remains many problems in outcomes and safety, particularly the high risk of hemorrhagic transformation. Here, a metal‐phenolic network (MPN)‐based nanoparticle hybrid tPA and targeting ligand (MPN@tPA@GP) is developed for tPA targeting delivery to local thrombus interior, achieving efficient pH‐sensitive tPA release and reduced hemorrhage risk for IS therapy. The binding and penetrating thrombi efficiency of 8 fibrin‐targeting peptides is screened in different types of thrombi made from human blood in vitro. The construction of a hybrid nanoparticle with tPA and GP targeting peptide (MPN@tPA@GP) can be achieved through a simple self‐assembly process and confirmed by FTIR, EDS, SDS‐PAGE, and disrupting agents, while Mg 2 ⁺ coordination is believed as the critical force in nanoparticle formation. This nanoparticle exhibited good fibrinolytic activity and pH‐responsive tPA release in vitro. In vivo targeting studies revealed excellent thrombus binding and penetrating capability in two animal models. Furthermore, MPN@tPA@GP displayed superior therapeutic efficacy with a reduced tPA‐induced hemorrhage risk, resulting from excellent thrombus targeting, pH‐responsive release, and Magnesium homeostasis maintenance. Thus, this nanoparticle offers a promising strategy to improve the efficacy and reduce the hemorrhage risk of thrombolytic therapy for IS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue Plasminogen ActivatorThrombolytic TherapyNanoparticlesHemorrhageAnimalsHumansMiceThrombosisHydrogen-Ion ConcentrationFibrinolytic AgentsDrug Delivery SystemsMale

Stichwörter der Autor:innen

ischemic strokemetal‐phenolic‐protein hybrid nanoparticlemicroenvironment responsethrombus targeted delivery

Substanzen

Tissue Plasminogen ActivatorFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmaceutical Sciences, Fudan University & Key Laboratory of Smart Drug Delivery, Ministry of Education & National Key Laboratory of Advanced Drug Formulations for Overcoming Deli…
  • Precision Medicine Research Center, School of Pharmacy, Binzhou Medical University, Yantai, Shandong Province, China.
  • Department of Pharmaceutics, School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang Province, China.
  • Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang Province, China.
  • Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
  • Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, Zhejiang Province, China.

ORCID-Profile: Xinyi Zhao, Jing Qin

Förderung

  • National Natural Science Foundation of China
  • Open Project Program of Key Lab of Smart Drug Delivery (Fudan University)

Zitieren

APA

Zhao, X., Wang, W., Shi, J., Zhou, Q., Zhao, Z., Li, C., Tang, M., Wang, J., Zhao, J., Zhang, H., & Qin, J. (2026). A Novel Metal‐Phenolic‐Protein Hybrid Nanoparticles With Precise Delivery and Enhanced Penetration Effect for tPA Targeted Thrombolysis and Reduced Hemorrhagic Risk. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503684

Vancouver

Zhao X, Wang W, Shi J, Zhou Q, Zhao Z, Li C, et al. A Novel Metal‐Phenolic‐Protein Hybrid Nanoparticles With Precise Delivery and Enhanced Penetration Effect for tPA Targeted Thrombolysis and Reduced Hemorrhagic Risk. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503684

BibTeX
@article{Zhao2026,
  author = {Zhao, Xinyi and Wang, Wendie and Shi, Jing and Zhou, Qi and Zhao, Zitong and Li, Chenyang and Tang, Mingshuai and Wang, Jing and Zhao, Jing and Zhang, Hong and Qin, Jing},
  title = {A Novel Metal‐Phenolic‐Protein Hybrid Nanoparticles With Precise Delivery and Enhanced Penetration Effect for tPA Targeted Thrombolysis and Reduced Hemorrhagic Risk},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202503684}
}
Kostenlos starten →